Filter By Category
Archives
Share on -
AVASOPASEM MANGANESE
Generic Name: AVASOPASEM MANGANESE
ABSTRACT -
Avasopasem manganese (GC4419) is an investigational manganese-containing small-molecule superoxide dismutase mimetic designed to convert superoxide to hydrogen peroxide and oxygen in radiation-associated tissue injury settings. Its molecular formula is C₂₁H₃₅Cl₂MnN₅. The chemical representation above shows the 2D coordination-complex structure.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE -
- Dosage should be determined only by a qualified healthcare professional.
- No approved public dosing regimen is established for routine clinical use unless specifically authorized in a local label.
- Clinical-study dosing, when applicable, is protocol-specific and must not be copied into routine practice.
- Do not administer outside an authorized clinical trial, compassionate-use pathway, or approved product labeling.
SIDE EFFECTS-
Possible side effects and safety concerns include:
- Nausea, vomiting, fatigue, headache, or taste disturbance
- Infusion-related discomfort or local reactions depending on formulation
- Hypotension, dizziness, or transient laboratory changes may occur
- Mucositis-related symptoms may still occur because the condition is multifactorial
- Serious hypersensitivity reactions are possible
ALLERGIC REACTIONS -
Hypersensitivity to Avasopasem Manganese or related compounds/products may occur. Symptoms may include:
- Immediate urticaria, itching, flushing, or generalized rash
- Facial, lip, tongue, or throat swelling
- Wheezing, chest tightness, or breathing difficulty
- Dizziness, fainting, severe hypotension, or collapse
- Anaphylaxis, although uncommon, requires emergency medical treatment
Important: Patients who develop an allergic reaction to Avasopasem Manganese should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS-
Avasopasem Manganese may interact with certain medicines, biologics, vaccines, protocols, or clinical conditions. Caution is needed with:
- Concurrent radiotherapy and chemotherapy require strict oncology protocol coordination.
- Other antioxidant or redox-active therapies should be reviewed.
- Renal/hepatic risk medicines may affect monitoring plans.
- Patients should inform providers about all medicines, supplements, and vaccines.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Administer only in oncology settings prepared for protocol monitoring.
- Monitor blood pressure, infusion tolerance, and laboratory parameters.
- Do not use as a substitute for standard mucositis prevention and supportive care.
- Pregnancy and lactation safety are not established unless specifically studied.
WARNINGS –
- Investigational status: safety and effectiveness for routine use may not be established.
- Serious or unexpected adverse events must be managed under protocol and reported promptly.
- Use only by personnel trained for the relevant formulation and administration route.
- Keep out of reach of children.
Share on -
. Developed by